Genesis Healthcare, Inc. (GENN)

OTCMKTS: GENN · Delayed Price · USD
+0.0008 (28.57%)
Aug 8, 2022 4:00 PM - Market closed

Total Valuation

GENN has a market cap or net worth of $602,462. The enterprise value is $3.46 billion.

Market Cap 602,462
Enterprise Value 3.46B

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

GENN has 167.35 million shares outstanding. The number of shares has decreased by -32.37% in one year.

Shares Outstanding 167.35M
Shares Change (YoY) -32.37%
Shares Change (QoQ) +0.13%
Owned by Insiders (%) 33.68%
Owned by Institutions (%) n/a
Float 74.77M

Valuation Ratios

PE Ratio n/a
Forward PE 0.01
PS Ratio n/a
Forward PS 0.00
PB Ratio n/a
P/FCF Ratio 0.01
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.76, with a EV/FCF ratio of 65.49.

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA 11.76
EV / EBIT 47.46
EV / FCF 65.49

Financial Position

Current Ratio 0.23
Quick Ratio 0.20
Debt / Equity n/a
Debt / EBITDA 12.96
Debt / FCF 72.16

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -1.40%
Return on Capital (ROIC) n/a
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count 44,000
Asset Turnover 0.91
Inventory Turnover n/a


Income Tax -3.61M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -98.50% in the last 52 weeks. The beta is 0.12, so GENN's price volatility has been lower than the market average.

Beta (1Y) 0.12
52-Week Price Change -98.50%
50-Day Moving Average 0.07
200-Day Moving Average 0.13
Average Volume (30 Days) 35,655

Short Selling Information

The latest short interest is 2.30 million, so 1.38% of the outstanding shares have been sold short.

Short Interest 2.30M
Short % of Shares Out 1.38%
Short % of Float 3.08%
Short Ratio (days to cover) 0.21

Income Statement

Revenue n/a
Gross Profit 2.27B
Operating Income -483.06M
Pretax Income -62.57M
Net Income -58.96M
Net Income Common n/a
EBITDA 294.02M
EBIT 72.87M
Earnings Per Share (EPS) -$0.53
Full Income Statement

Balance Sheet

The company has $352.75 million in cash and $3.81 billion in debt, giving a net cash position of -$3.46 billion or -$20.66 per share.

Cash & Cash Equivalents 352.75M
Total Debt 3.81B
Net Cash -3.46B
Net Cash Per Share -$20.66
Book Value -820.22M
Book Value Per Share -4.90
Working Capital -2.98B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $315.73 million and capital expenditures -$262.93 million, giving a free cash flow of $52.80 million.

Operating Cash Flow 315.73M
Capital Expenditures -262.93M
Free Cash Flow 52.80M
FCF Per Share $0.32
Full Cash Flow Statement


Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

GENN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield 8,764.37%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield 32.34%
Shareholder Yield 32.34%
Dividend Details

Analyst Forecast

The average price target for GENN is $0.44, which is 12,122.22% higher than the current price. The consensus rating is "Sell".

Price Target $0.44
Price Target Difference 12,122.22%
Analyst Consensus Sell
Analyst Count 6
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a